FDA Approves Nelarabine Injection for T-cell Leukemia and Lymphoma

Press/Media

Period	13 Mar 2023

Media coverage

Title	FDA Approves Nelarabine Injection for T-cell Leukemia and Lymphoma
Media name/outlet	OncLive
Country/Territory	United States
Date	13/03/23
URL	ct.moreover.com/?a=50239371199&p=1gw&v=1&x=MTKIkRLP3ufSBjozs7xVkg
Persons	Stephen Hunger